A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol provides a streamlined workflow to generate and test human chimeric antigen receptor regulatory T cells (CAR Tregs).
Chimeric antigen receptor (CAR) T-cell therapy has reshaped the face of cancer treatment, leading to record remission rates in previously incurable hematological cancers. These successes have spurred interest in adapting the CAR platform to a small yet pivotal subset of CD4+ T cells primarily responsible for regulating and inhibiting the immune response, regulatory T cells (Tregs). The ability to redirect Tregs' immunosuppressive activity to any extracellular target has enormous implications for creating cell therapies for autoimmune disease, organ transplant rejection, and graft-versus-host disease. Here, we describe in detail methodologies for bona fide Treg isolation from human peripheral blood, genetic modification of human Tregs utilizing either lentivirus or CRISPR/Cas9-aided knock-in using adeno-associated virus-mediated homologous directed repair (HDR) template delivery, and ex vivo expansion of stable human CAR Tregs. Lastly, we describe the assessment of human CAR Treg phenotypic stability and in vitro suppressive function, which provides insights into how the human CAR Tregs will behave in preclinical and clinical applications.
Chimeric antigen receptor (CAR) T-cell therapies have revolutionized the treatment of hematological malignancies, achieving remarkably high remission rates in previously untreatable cancers1,2. Encouraging early results using CAR T cells to treat glioblastoma3,4,5 highlight CAR technology's versatility and future potential to target a wide range of malignancies. As the field explores further applications of CARs, regulatory T cells (Tregs) have emerged as a promising cell type. Tregs play a crucial role in maintai....
1. Human Treg isolation
The protocol described here provides a streamlined and standardized pipeline to assess new chimeric antigen receptor (CAR) constructs in human regulatory T cells (Tregs), with the aim of creating living therapeutics for autoimmune disease, graft-versus-host disease, organ transplant rejection, and allergy. Figure 1 depicts how we obtain highly pure human Tregs from peripheral blood using FACS (Figure 1A), as evaluated by their high levels of the Treg lineage tra.......
This protocol provides a streamlined and comprehensive methodology for generating and evaluating human chimeric antigen receptor regulatory T cells (CAR Tregs). The success of CAR technology in treating hematological cancers has inspired its application to the immunosuppressive subset of T cells, Tregs. Unlike conventional T cells, Tregs inhibit immune responses, offering potential treatments for conditions resulting from unwanted immunity, such as autoimmune disease, organ transplant rejection, graft-versus-host disease.......
LMRF is funded by Human Islet Research Network (HIRN) Emerging Leader in Type 1 Diabetes grant U24DK104162-07, American Cancer Society (ACS) Institutional Research Grant IRG-19-137-20, South Carolina Clinical and Translational Research (SCTR) Pilot Project Discovery Grant 1TL1TR001451-01, Diabetes Research Connection (DRC) Grant IPF 22-1224, and Swim Across America Grant 23-1579. RWC is supported by the Cellular, Biochemical and Molecular Sciences training grant T32GM132055 and Hollings Cancer Center Lowvelo Graduate Fellowship. This study was supported in part by the Flow Cytometry and Cell Sorting Shared Resource, Hollings Cancer Center, Medical University of South ....
Name | Company | Catalog Number | Comments |
Adeno-associated virus (AAV) | Charles River Laboratories | ||
CAR target-expressing K562 cells | e.g., CD19-K562 | ||
Cesium-137 irradiator | |||
Anti-human CD8 PerCP (clone SK1) | Biolegend | 344708 | |
Anti-human CD4 PE/Cy7 (clone SK3) | Biolegend | 344612 | |
DynaMag-15 magnet | ThermoFisher | 12301D | |
Ghost BV510 viability dye | TONBO | 13-0870-T100 | |
K562 cells | American Type Culture Collection | CCL-243 | |
0.5 M EDTA, pH 8.0 | Gibco | 15575020 | |
1 M HEPES | Gibco | 15630080 | |
Ammonium chloride solution | STEMCELL Technologies | 7850 | |
Anti-human CD127 PE (clone hIL-7R-M21) | BD Biosciences | 557938 | |
Anti-human CD25 APC (clone BC96) | Biolegend | 302610 | |
Anti-human CD4 FITC (clone SK3) | Biolegend | 344604 | |
Anti-human CD71 PE (clone SK1) | Biolegend | 334106 | |
Anti-human CD8 PerCP (clone SK1) | Biolegend | 344707 | |
Anti-human CTLA-4 PerCP-e710 | ThermoFisher | 46-1529-42 | |
Anti-human EGFR APC (clone AY13) | Biolegend | 352905 | |
Anti-human FOXP3 eFluor 450 | ThermoFisher | 48-4776-42 | |
Anti-human HELIOS PE | Biolegend | 137216 | |
Ca2+ and Mg2+ free Dulbecco’s Phosphate Buffered Saline (DPBS) | Gibco | 14190144 | |
Cell counter (TC20 Automated Cell Counter) | Bio-Rad | 1450102 | |
Cell Counting Slides | Bio-Rad | 1450016 | |
CellTrace Violet Cell Proliferation Kit | ThermoFisher | C34571 | |
DNA LoBind Tubes | Eppendorf | 22431021 | |
Easy 50 EasySep magnet | STEMCELL Technologies | 18002 | |
EasySep Human CD4+ T cell Enrichment Kit | STEMCELL Technologies | 19052 | |
EasySep Human CD8+ T cell Enrichment Kit | STEMCELL Technologies | 19053 | |
EasySep magnet | STEMCELL Technologies | 18000 | |
eBioscience Foxp3 transcription factor staining buffer set | ThermoFisher | 00-5523-00 | |
Falcon Round-Bottom Polystyrene Test Tubes with Cell Strainer Snap Cap, 5 mL | Fisher Scientific | 08-771-23 | 40μm |
Fetal Bovine Serum (FBS) | Gibco | 26140079 | |
Flow cytometer | Beckman Coulter | CytoFLEX LX U3-V5-B3-Y5-R3-I2 | |
Fluorescence-activated cell sorter | BD Biosciences | FACS Aria III Cell Sorter | |
GlutaMAX | Gibco | 35050061 | |
Human CD3/28 T Cell Expansion and Activation Dynabeads | Gibco | 11131D | |
Invitrogen Neon Transfection System | ThermoFisher | 10431915 | |
Invitrogen Neon Transfection System 100 μL Kit | ThermoFisher | 10114334 | |
Lentivirus | VectorBuilder | ||
MEM Non-Essential Amino Acids Solution | Gibco | 11140050 | |
Myc Tag antibody A647 (clone 9B11) | Cell Signaling Technologies | 2233S | |
Opti-MEM I Reduced Serum Medium | ThermoFisher | 31985062 | |
Penicilin-Streptomycin solution | Gibco | 15140122 | |
Recombinant human interleukin-2 (rhIL-2) | Peprotech | 200-02 | |
RPMI 1640 medium, no glutamine | Gibco | 11875093 | |
Sodium pyruvate | Gibco | 11360070 | |
Spectral Flow Cytometer | Cytek | Northern Lights | |
TRAC gRNA | Synthego | Sequence (CAGGGTTCTGGATATCTGT) | |
TrueCut Cas9 Protein v2 | ThermoFisher | A36496 | |
Trypan Blue solution | Sigma | T8154-100ML | |
1/10 Leukopak | STEMCELL Technologies | 200-0092 | 1-2 billion PBMC |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved